AR020067A1 - Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma - Google Patents

Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma

Info

Publication number: AR020067A1
Authority: AR; Argentina
Prior art keywords: cell; melanoma; composition; membrane; tumor response
Prior art date: 1998-04-09

Application number

ARP990101625A

Other languages

English (en)

Spanish (es)

Original Assignee

Univ Jefferson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-09

Filing date

1999-04-09

Publication date

2002-04-10

1999-04-09 Application filed by Univ Jefferson filed Critical Univ Jefferson

2002-04-10 Publication of AR020067A1 publication Critical patent/AR020067A1/es

Links

201000001441 melanoma Diseases 0.000 title abstract 8
230000006023 anti-tumor response Effects 0.000 title abstract 4
206010027476 Metastases Diseases 0.000 title abstract 3
230000009401 metastasis Effects 0.000 title abstract 3
210000004027 cell Anatomy 0.000 abstract 8
239000012528 membrane Substances 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
210000001744 T-lymphocyte Anatomy 0.000 abstract 2
210000004072 lung Anatomy 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
206010027480 Metastatic malignant melanoma Diseases 0.000 abstract 1
210000000170 cell membrane Anatomy 0.000 abstract 1
238000000605 extraction Methods 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
230000001394 metastastic effect Effects 0.000 abstract 1
208000021039 metastatic melanoma Diseases 0.000 abstract 1
206010061289 metastatic neoplasm Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/876—Skin, melanoma

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ARP990101625A 1998-04-09 1999-04-09 Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma AR020067A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8125698P	1998-04-09	1998-04-09

Publications (1)

Publication Number	Publication Date
AR020067A1 true AR020067A1 (es)	2002-04-10

Family

ID=22163059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP990101625A AR020067A1 (es)	1998-04-09	1999-04-09	Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma

Country Status (8)

Country	Link
EP (1)	EP1067960A2 (pl)
JP (1)	JP2003524583A (pl)
CN (1)	CN1301174A (pl)
AR (1)	AR020067A1 (pl)
AU (1)	AU3482199A (pl)
CA (1)	CA2327339A1 (pl)
PL (1)	PL366240A1 (pl)
WO (1)	WO1999052546A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000057911A2 (en)	1999-03-16	2000-10-05	Thomas Jefferson University	Hapten-conjugated mammalian cells and methods of making and using thereof
JP2004507446A (ja) *	2000-02-04	2004-03-11	トーマス・ジェファーソン・ユニバーシティ	低用量ハプテン化腫瘍細胞および腫瘍細胞抽出物の免疫治療
US7297330B2 (en)	2000-02-04	2007-11-20	Thomas Jefferson University	Low dose haptenized tumor cell and tumor cell extract immunotherapy
WO2003103389A2 (en)	2002-06-10	2003-12-18	Avax Technologies Inc.	Cryopreservation of haptenized tumor cells
FR3011850B1 (fr) *	2013-10-15	2018-04-06	Cfl Biotech	Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
GB2630768B (en) *	2023-06-07	2025-07-02	Alv B As	Administration of bacterial composition for use in treatment of lung metastases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2302337T3 (es) *	1995-06-07	2008-07-01	Thomas Jefferson University	Extracto de celulas tumorales modificadas con hapteno y procedimientos para tratar cancer.
PL328790A1 (en) *	1996-10-04	1999-02-15	Univ Jefferson	T-lymphocytes provoking an immunological response and methods of using them
AU2686999A (en) *	1998-02-17	1999-08-30	Thomas Jefferson University	Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes

1999
- 1999-04-09 AR ARP990101625A patent/AR020067A1/es unknown
- 1999-04-09 EP EP99916518A patent/EP1067960A2/en not_active Withdrawn
- 1999-04-09 CN CN99806236A patent/CN1301174A/zh active Pending
- 1999-04-09 JP JP2000543156A patent/JP2003524583A/ja active Pending
- 1999-04-09 PL PL99366240A patent/PL366240A1/pl unknown
- 1999-04-09 AU AU34821/99A patent/AU3482199A/en not_active Abandoned
- 1999-04-09 WO PCT/US1999/007725 patent/WO1999052546A2/en not_active Ceased
- 1999-04-09 CA CA002327339A patent/CA2327339A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999052546A3 (en)	1999-12-16
CA2327339A1 (en)	1999-10-21
PL366240A1 (pl)	2005-01-24
CN1301174A (zh)	2001-06-27
AU3482199A (en)	1999-11-01
EP1067960A2 (en)	2001-01-17
WO1999052546A2 (en)	1999-10-21
JP2003524583A (ja)	2003-08-19

Similar Documents

Publication	Publication Date	Title
ES2104072T3 (es)	1997-10-01	Redistribucion de composiciones de policarbonato organico.
DE69941713D1 (de)	2010-01-07	Abstammungs-spezifische zellen und vorläuferzellen
ES260079A1 (es)	1960-12-16	Procedimiento para tenir el cabello
ES2059207T3 (es)	1994-11-01	Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
UY27069A1 (es)	2002-07-31	Activadores de glucocinasa del tipo isoindolin-1-ona
MX2010003110A (es)	2010-05-19	Composiciones de polipeptido de elemento nuclear intercalado largo y metodos de uso de las mismas.
ES2175462T3 (es)	2002-11-16	Composiciones cristalizables que comprenden un complejo del dominio de proteasa ns3 del virus de la hepatitis c/ns4a, y cristales asi obtenidos.
GT201000037A (es)	2012-04-30	Depsipéptidos cíclicos
ATE339963T1 (de)	2006-10-15	Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung
AR067980A1 (es)	2009-10-28	Peptidos de cdh3 y agentes que los comprenden
DK1392335T3 (da)	2007-09-17	Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite
AR020067A1 (es)	2002-04-10	Uso y composicion para inducir una respuesta anti-tumoral contra una metastasis de melanoma
GT200800307A (es)	2009-11-03	18-metil-19-nor-androst-4-en-17,17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen
AR246160A1 (es)	1994-07-29	Preservativo para composiciones acuosas.
PA8577701A1 (es)	2004-02-07	Polipeptido t20 pegilado
ES8900046A1 (es)	1988-11-16	Un procedimiento para la preparacion de epipodofilotoxina
ECSP034532A (es)	2003-05-26	Derivados del 1-aminobutan-3-ol sustituido
DK578887D0 (da)	1987-11-04	Antihypertensiva
AR034065A1 (es)	2004-01-21	Productos capilares que contienen aceites naturales con esteroles y acidos grasos insaturados y empleo de aceites naturales y de preparaciones
MX9307203A (es)	1994-07-29	COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ES2172967T3 (es)	2002-10-01	Metilciclotetradec-5-en-1-ona.
CO5680457A2 (es)	2006-09-29	Moleculas de union de nogo-a y uso farmaceutico de las mismas
ES2161643B1 (es)	2002-06-16	Mejoras en la patente principal numero 9900887 " procedimiento para la obtencion y refuerzo de laminas de piedra natural de pequeño espesor.
GT200600106A (es)	2006-11-07	Agentes endoparasiticidas
UY26307A1 (es)	2001-04-30	Las rutas sintéticas eficientes para la preparación de los inhibidores de la proteasa del rinovirus y los intermedios claves